Skip to content
Open access

LINE-1 transposon derepression and epigenetic remodeling in Retinoblastoma

Jul 2026 · bioRxiv · 0 citations · 45 references
Biology

TL;DR

It is shown that retinoblastoma is associated with LINE-1 promoter hypomethylation, increased LINE-1 transcript expression, ORF1p accumulation, and preferential activation of selected LINE-1 loci, which is associated with altered expression of oncogenic signalling pathways and host factors involved in transposable element repression.

Read PDF

Similar papers

Sep 2026

Abstract A038: LINE-1 remodel pancreatic ductal adenocarcinoma metastatic plasticity

Retrotransposons comprise most of the human dark genome and are frequently upregulated during cancer progression. Long interspersed nuclear element-1 (LINE-1), the only autonomously active human retrotransposon, is aberrantly reactivated in pancreatic ductal adenocarcinoma (PDAC), yet how LINE-1 regulates metastatic...

Ching Ngar Wong, Fabricio R. Neira, Cristina Pedorella et al. · 0 citations
Open access Aug 2026

Comprehensive Analyses of SOX7 Provide Novel Insights on Its Tumor Suppressor Role and Its Target Genes with Therapeutic Implications in Multiple Myeloma

Results indicate that SOX7 functions as a tumor suppressor in MM, and its inactivation promotes cell cycle progression, and the anti-myeloma effects of panobinostat in MM.1S cells may be partially mediated through SOX7 induction.

Arda Ceylan, Xiao-Zhou Hu, Tevfik Hatipoğlu et al. · 0 citations
Sep 2026

Abstract A027: Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer

It is demonstrated for the first time that LOY is significantly enriched in advanced-stage disease and the aggressive basal molecular subtype, establishing LOY as a causal genetic driver of PDAC progression, acting through epigenetic remodeling to promote EMT, basal subtype identity, metastasis, and therapy resistance.

M. Dorsch, Felix E. G. Beaudry, A. Baginska et al. · 0 citations
Open access Sep 2026

FHL1 Downregulation Is Specific to Cancer-Associated Fibroblasts and Linked to Reduced Chromatin Accessibility in Colorectal Cancer

Background/Objectives: Colorectal cancer (CRC) is among the most diagnosed malignancies and is a leading cause of cancer-related deaths globally. Beyond canonical CRC driver mutations, additional molecular alterations such as dysregulated gene expression and epigenetic reprogramming shape the disease behavior and may r...

Abdullah A. Alqasem, Waad Al-Burayk, Muneira Habjar et al. · 0 citations
Sep 2026

Abstract B010: ELUCIDATING DNA DAMAGE REPAIR SIGNALING AND THERAPEUTIC VULNERABILITIES ACTIVATED BY TRANSPOSASE-DERIVED PGBD5

One hallmark of pediatric tumors is their low mutational burden, which contrasts with adult tumors, where cancer-causing mutations often accumulate over decades of DNA replication and environmental exposure. This raises the question of how such mutations arise in young patients. We have proposed that developmental mu...

Helen S. Mueller, Kaisha Garvin, Sophia Rha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.